Genetic studies of drug response and side effects in the STAR*D study, part 1.
Garriock
Holly A
HA
Department of Psychiatry and Institute for Human Genetics, University of California, San Francisco, 94143-0984, USA.
Hamilton
Steven P
SP
D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000235:genetics*; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics; D055106:Genome-Wide Association Study; D006801:Humans; D010597:Pharmacogenetics; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics; D016896:Treatment Outcome
D000928:Antidepressive Agents; D005819:Genetic Markers; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins